chr3-191375645-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000392455.9(CCDC50):c.976+56A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.55 in 1,553,668 control chromosomes in the GnomAD database, including 244,167 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.64 ( 32370 hom., cov: 31)
Exomes 𝑓: 0.54 ( 211797 hom. )
Consequence
CCDC50
ENST00000392455.9 intron
ENST00000392455.9 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.381
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 3-191375645-A-G is Benign according to our data. Variant chr3-191375645-A-G is described in ClinVar as [Benign]. Clinvar id is 1192702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.896 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC50 | NM_178335.3 | c.976+56A>G | intron_variant | ENST00000392455.9 | NP_848018.1 | |||
CCDC50 | NM_174908.4 | c.449-4514A>G | intron_variant | NP_777568.1 | ||||
CCDC50 | XM_011512460.2 | c.976+56A>G | intron_variant | XP_011510762.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC50 | ENST00000392455.9 | c.976+56A>G | intron_variant | 1 | NM_178335.3 | ENSP00000376249 | P3 | |||
CCDC50 | ENST00000392456.4 | c.449-4514A>G | intron_variant | 1 | ENSP00000376250 | A1 |
Frequencies
GnomAD3 genomes AF: 0.637 AC: 96652AN: 151778Hom.: 32305 Cov.: 31
GnomAD3 genomes
AF:
AC:
96652
AN:
151778
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.541 AC: 758164AN: 1401770Hom.: 211797 AF XY: 0.543 AC XY: 378268AN XY: 696028
GnomAD4 exome
AF:
AC:
758164
AN:
1401770
Hom.:
AF XY:
AC XY:
378268
AN XY:
696028
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.637 AC: 96776AN: 151898Hom.: 32370 Cov.: 31 AF XY: 0.645 AC XY: 47850AN XY: 74204
GnomAD4 genome
AF:
AC:
96776
AN:
151898
Hom.:
Cov.:
31
AF XY:
AC XY:
47850
AN XY:
74204
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2794
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 22, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Autosomal dominant nonsyndromic hearing loss 44 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at